Oversold

ORGO

Same as last week
Valuation50/ 100
Cash flow & growth49/ 100
Upside potential39/ 100
Risk potential60/ 100

ORGO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +6.3%, operating margin -3 percentage points. Free cash flow is 4.6% of revenue. The business score is 49.4/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 38.7% upside, or about $2.37.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

The 60% downside is driven by operating stress: the model assumes earnings fall 38.4% and the PE falls 35.1%. That gives $0.05 per share at a 13.5× PE, or about $0.68. Price swings alone suggest 56.3% downside.

This is a scenario based on our model, not a forecast or probability.

ORGO vs Historical averages

MetricCurrentAverageRelative
PE21x32x35% lower
PE percentile46508% lower
EPS-$0.83$0.14676% lower
FCF$20.8M$694K2,903% higher
Loading historical comparisons…

ORGO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

ORGO Forward outlook

MetricOutlook
Forward valuation--
Forward earningsLoss narrowing
Forward revenueStrong decline
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionModerate

ORGO’s outlook is mixed, with declining sales expectations a concern.

ORGO PE Valuation

Loading pe valuation table…

This table applies ORGO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

ORGO Earnings Per Share

Loading earnings per share…

This chart tracks ORGO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

ORGO Quarterly Revenue

Loading quarterly revenue…

This chart tracks ORGO's quarterly revenue over time and shows how sales are changing from year to year.

ORGO Free Cash Flow

Loading free cash flow…

This chart tracks ORGO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

ORGO Total Shares

Loading shares over time…

This chart tracks changes in ORGO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

ORGO Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

ORGO PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares ORGO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

ORGO Weekly Price

Loading weekly price…

This chart uses ORGO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

ORGO Weekly Moving Averages

Loading weekly moving averages…

This chart compares ORGO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

ORGO Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.